Determination of benzydamine and its N-oxide in biological fluids by high-performance liquid chromatography.

G A Baldock, R R Brodie, L F Chasseaud, T Taylor

Index: J. Chromatogr. A. 529(1) , 113-23, (1990)

Full Text: HTML

Abstract

A simple, sensitive and selective method for the determination of benzydamine in human plasma and urine, and for benzydamine N-oxide in urine, has been developed using high-performance liquid chromatography in the reversed-phase mode. The limit of reliable determination of benzydamine in plasma was 0.5 ng/ml and that in urine 1 ng/ml; the limit of reliable determination of benzydamine N-oxide in urine was 50 ng/ml. The method has been successfully applied to the analysis of these compounds in biological fluids after administration of intravenous and oral doses of benzydamine to human volunteers.


Related Compounds

Related Articles:

HPLC determination of benzydamine and its metabolite N-oxide in plasma following oral administration or topical application in man, using fluorimetric detection.

1986-04-01

[Pharmacol. Res. Commun. 18(4) , 385-403, (1986)]

Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver.

1998-09-16

[Biochim. Biophys. Acta 1425(1) , 41-6, (1998)]

Biotransformation of benzydamine by microsomes and precision-cut slices prepared from cattle liver.

2002-01-01

[Xenobiotica 32(1) , 73-86, (2002)]

Can caffeine metabolism be used as an in-vivo probe for human flavin-containing monooxygenase activity?

2000-04-01

[Pharmacogenetics 10(3) , 275-7, (2000)]

More Articles...